Ovarian cancer is the leading cause of death from gynecologic cancer in
the developed countries. It is usually diagnosed in advanced stage since
it is often symptomless or symptoms are nonspecific in early course of
the disease. It has a high recurrence rate and poor prognosis in
advanced disease. Ovarian cancer has distinct type of disease spread in
abdomen and above diaphragm. Surgery is irreplaceable in staging but
multimodality imaging approach is often needed during the diagnosis,
treatment monitoring, and follow-up of patients with ovarian cancer,
typically ultrasound, CT, MRI and PET/CT are the main modalities used.
The current clinical role of PET/CT in evaluation of ovarian cancer
during staging, treatment prognostication and response assessment, and
in disease recurrence is discussed in this review compared to
conventional imaging.